Article
Navigating complexities in ADC development with specialized global laboratory support and scientific expertise
April 8, 2024
A global biopharmaceutical client developing a pipeline of complex antibody-drug conjugates (ADCs) needed a reliable global lab partner. Given the range of cancer applications and the challenges involved in optimizing ADC components and characterizing these multifaceted biopharmaceuticals, the client sought comprehensive lab services and scientific expertise to support their clinical trials through commercialization.